INTEGREX
DEAD

Serial Number

76406884

Owner

Integrated Research, LLC

Attorney

JAMES L. BIKOFF, ESQ.

First Use Date

Aug 12, 2003

Filing Date

May 6, 2002

Add to watchlist:

No watchlists yet
View on USPTO

INTEGREX Trademark

Serial Number: 76406884 • Registration: 2936622

INTEGREX is a trademark filed by Integrated Research, LLC on May 6, 2002. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Integrated Research, LLC (2 trademarks)

505 S. Main Street, Suite 950
Orange, CA 92868

Entity Type: 16

Integrium, LLC (8 trademarks)

14351 Myford Road
Tustin, CA 92780

Entity Type: 16

Trademark Details

Filing Date

May 6, 2002

Registration Date

March 29, 2005

First Use Anywhere

August 12, 2003

First Use in Commerce

August 12, 2003

Published for Opposition

September 23, 2003

Cancellation Date

November 4, 2011

Goods & Services

TRAINING CLINICAL TRIAL SITE PERSONNEL CONCERNING DRUG PROTOCOL REQUIREMENTS AND THE USE OF TESTS AND RATING SYSTEMS FOR SUCH PROTOCOL; TRAINING CLINICAL TRIAL PERSONNEL IN THE USE OF MEDICAL AND RESEARCH EQUIPMENT REQUIRED BY DRUG AND/OR DEVICE PROTOCOLS; ARRANGING MEDICAL CONFERENCES AND SYMPOSIA; PROVIDING CONTINUING MEDICAL EDUCATION TO PHYSICIANS AND OTHER HEALTH-CARE PROVIDERS AND ARRANGING AND MANAGING SPEAKERS' BUREAUS IN CONJUNCTION THEREWITH; MEDICAL MANUSCRIPT PREPARATION AND SUBMISSION; DEVELOPMENT AND PUBLICATION OF MEDICAL JOURNALS

MANAGEMENT ASSISTANCE FOR CLINICAL TRIALS OF INVESTIGATIONAL DRUGS, NAMELY, ARRANGING FOR SITES TO PERFORM CLINICAL TRIALS, ARRANGING FOR THE IMPORT, PACKAGING, SHIPPING, LABELING, AND DISTRIBUTION OF DRUGS AND OTHER INVESTIGATIONAL SUPPLIES AND EQUIPMENT TO AND FROM THE CLINICAL TRIAL SITES, ARRANGING FOR THE CENTRAL COLLECTION OF LABORATORY SPECIMENS FROM CLINICAL TRIAL SITES, MAKING ANY AND ALL FILINGS REQUIRED BY THE FOOD AND DRUG ADMINISTRATION FOR INVESTIGATIONAL NEW DRUGS AND NEW DRUG APPLICATIONS, PREPARING STATISTICAL REPORTS RESULTING FROM CLINICAL TRIALS; COOPERATIVE ADVERTISING AND MARKETING OF NEW DRUGS

PROVIDING MEDICAL MONITORING SERVICES, NAMELY REVIEW OF TRAIL DATA REPORTS FOR SAFETY PURPOSES, AND TO DETERMINE AND ASSURE COMPLIANCE WITH CLINICAL STUDY PROTOCOL REQUIREMENTS AS WELL AS COMPLIANCE WITH GOOD CLINICAL PRACTICES AND FOOD AND DRUG ADMINISTRATION AND/OR OTHER REGULATIONS GOVERNING CLINICAL TRIALS

TECHNICAL WRITING OF CLINICAL TRIAL REPORTS FOR OTHERS; DATABASE DEVELOPMENT SERVICES TO PROCESS DATA COLLECTED FROM CLINICAL TRIALS; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 4, 2011 C8..
REGISTERED-PRINCIPAL REGISTER
Mar 29, 2005 R.PR
ASSIGNED TO LIE
Sep 22, 2004 ALIE
LAW OFFICE REGISTRATION REVIEW COMPLETED
Sep 21, 2004 REGV
ASSIGNED TO LIE
Sep 20, 2004 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 1, 2004 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 28, 2004 SUPC
USE AMENDMENT FILED
Jun 15, 2004 IUAF
PAPER RECEIVED
Jun 15, 2004 MAIL
CASE FILE IN TICRS
Jun 11, 2004 CFIT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 16, 2003 NOAM
PUBLISHED FOR OPPOSITION
Sep 23, 2003 PUBO
NOTICE OF PUBLICATION
Sep 3, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 24, 2003 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2003 CRFA
PAPER RECEIVED
Feb 3, 2003 MAIL
NON-FINAL ACTION MAILED
Sep 26, 2002 CNRT
ASSIGNED TO EXAMINER
Sep 4, 2002 DOCK
ASSIGNED TO EXAMINER
Aug 30, 2002 DOCK